CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Acquisition includes CAPLYTA ® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression ... the treatment of schizophrenia in adults Promising clinical-stage ...

All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being ...

Conversations about personal mental health issues seem to be shifting. Meet three Brevard residents who believe it's time to ...

Boehringer Ingelheim announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia ...

Presentation Operator Good morning and welcome to Johnson and Johnson's fourth quarter 2024 earnings conference call. All ...

Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...

How can you live longer and healthier in 2025? Discover the 3 key habits- better diet, exercise, and social connections- that ...